The French speciality pharmaceutical company, Juvisé Pharmaceuticals acquires two oncology products from Astrazeneca

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed id felis luctus, venenatis dolor non, sagittis leo. Nulla a suscipit elit, ut tempor nunc. Suspendisse accumsan nibh eget velit sodales condimentum.